Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Convalescent Plasma EUA ‘Could Have Been Done Better’ But Not A ‘Total Catastrophe’ – FDA’s Marks
Feb 11 2022
•
By
Sue Sutter
The size of the COVID-19 convalescent plasma expanded access program ballooned out of control, FDA's Peter Marks says. • Source: Alamy
More from Review Pathways
More from Pathways & Standards